Found 141 matching trials
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
PHASE2This is a single arm, multicenter phase II trial for 60 patients with untre...
AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer
PHASE3This is a phase 3 study. All subjects are patients with unresectable locall...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital
PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma
PHASE2Reported in the 2018 NEJM (378; 1277) article, the combination of checkpoin...
Location
Multiple Locations
A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.
PHASE2This study is designed as a prospective, randomized, open-label, phase II c...
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH), Beijing, 100730
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
PHASE1This is a two-part Phase 1/2 dose escalation and dose expansion study of an...
Location
Research Facility
Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies
PHASE1This is a phase I, open-label study to assess the safety, tolerability, pha...
Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma
EARLY_PHASE1The primary objective of this pilot study is to assess the feasibility of m...
Location
Multiple Locations
Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck
PHASE2The purpose of this study is to determine the efficacy and safety of invest...
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
PHASE2DESTINY-Gastric03 will investigate the safety, tolerability, pharmacokineti...
Status
Active Not Recruiting
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
PHASE3This is a randomized, open-label, multi-center, global, Phase III study to ...
Status
Active Not Recruiting